PASG (Passage Bio) Insider Ownership: 59.27 % (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PASG Passage Bio Inc PASG
32 GF Score
Price $4.96
! 2 Warning Signs
View Full Analysis

What is Passage Bio Insider Ownership?

Passage Bio PASG +2.28% 32 Insider Ownership is 59.27 % as of Jul. 26, 2026. GuruFocus rates PASG with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Passage Bio's insider ownership is 59.27%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Passage Bio's Institutional Ownership is 59.44%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Passage Bio's Float Percentage Of Total Shares Outstanding is 80.25%.


Passage Bio Insider Ownership Historical Data

* Premium members only.

The historical data trend for Passage Bio's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Passage Bio Insider Ownership Chart

Passage Bio Historical Data

The historical data trend for Passage Bio can be seen below:

2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 3.11 62.22 60.83 60.83 60.83 60.83 59.90 59.90 59.36 59.27
PASG
32GF Score
Passage Bio Inc PASG
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Passage Bio Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 59.27 % mean?
Passage Bio (PASG) has a Insider Ownership of 59.27 % as of Jul. 26, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Passage Bio and its competitors.
Is Passage Bio's Insider Ownership too high?
Passage Bio's current Insider Ownership is 59.27 %. Overall, Passage Bio has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Passage Bio's Insider Ownership compare to CTXR and HIND?
Passage Bio's Insider Ownership of 59.27 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Passage Bio and its competitors. Passage Bio's current Insider Ownership is 59.27 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Passage Bio stock overvalued right now?
Passage Bio (PASG) has a current Insider Ownership of 59.27 %. The current Insider Ownership is 59.27 %. Passage Bio's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Passage Bio (PASG), the current Insider Ownership is 59.27 % as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Passage Bio Business Description

Address 2005 Market Street, 39th Floor, One Commerce Square, Philadelphia, PA, USA, 19103
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
32GF Score

Get the complete analysis for PASG

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.96
Price